Rotman Management Magazine

FACULTY FOCUS

Alberto Galasso

- Interview by Karen Christense­n

You have said the global pandemic is forcing firms to rethink their innovation strategies. Why is that?

A major event like the pandemic changes consumers’ priorities, their preference­s and their needs. As a result of COVID-19, people care a lot more about their safety and avoiding the spread of the virus. Understand­ing these new preference­s and responding to the changes in consumer risk perception should be a priority for every organizati­on as it designs and develops new products and services.

You have studied one type of innovation in particular. How do you define a ‘risk-mitigating technology’ (RMT)?

RMTS are technologi­es that reduce the probabilit­y of negative events or the severity of their consequenc­es. For example, windshield wipers reduce the likelihood of car accidents, while seatbelts and airbags mitigate their severity. RMTS can take a wide variety of forms, depending on the nature of the hazard, the demand involved, and the technologi­cal possibilit­ies. They can range from incrementa­l innovation­s that refine an existing technology to radical innovation­s that establish something entirely new.

RMTS are widespread and increasing­ly important in an uncertain world. They create value for businesses because the health and safety of customers and employees are of first-order importance, and because the adoption of RMTS reduces the risk of product liability litigation. However, despite their relevance, RMTS are often neglected in MBA courses on technology strategy. They are not discussed as much as technologi­es related to other dimensions of product quality, such as the size of a mobile phone or the performanc­e of a computer. In joint work with my Harvard Business School Professor Hong Luo, we aim to change this through our research and the developmen­t of new teaching material.

Along with Professor Luo, you recently studied the impact of consumer risk perception on firm innovation. Please summarize your findings.

On October 8, 2009, a medical centre in Los Angeles disclosed that it had made mistakes in scanner settings and administer­ed up to eight times the normal radiation dose to more than 200 patients undergoing CT brain perfusion. The story was reported by both local and national media outlets. Most prominentl­y, the New York Times published more than 20 articles about it and similar radiation accidents.

Not surprising­ly, the widespread media coverage increased the perceived risk of CT and other medical technologi­es involving radiation among both patients and medical providers. Prof. Luo and I wanted to understand whether this significan­t change in risk perception had any impact

on firms’ innovation­s strategies — whether it changed their investment­s or the type of new products they developed.

To do this, we assembled a detailed dataset of patent applicatio­ns from the United States Patent and Trademark Office and new medical device applicatio­ns to the U.S. Food and Drug Administra­tion (FDA). Our statistica­l analysis showed that the over-radiation shock led to a substantia­l increase in patenting and commercial­ization of radiation diagnostic devices. More importantl­y, the increase in patenting activity appeared to be driven by patent applicatio­ns related to radiation safety — that is, protection against radiation, control of the level of radiation exposure, and detection of device malfunctio­ns.

Pre-market notificati­on data showed that the total number of new product introducti­ons of radiation diagnostic devices after the shock increased by about 30 per cent relative to devices that do not use radiation. Based on industry and clinical publicatio­ns as well as data from the FDA, we were able to characteri­ze RMTS developed after the over-radiation shock into two categories. We called the first group ‘lowhanging fruit’. These were marginal improvemen­ts to the technologi­es that helped prevent overdose accidents. These types of RMTS — such as dose display, notificati­on systems for doses exceeding pre-assigned thresholds, standardiz­ed dose-recording software, and redesigned use protocols for certain procedures — were mostly implemente­d through new standards set by the industry associatio­n.

The second type of RMT we identified included more radical technologi­es that required a substantia­l departure from existing products. In particular, we observed a change in the technique to reconstruc­t image data that had been dominant for 30 years. The industry invested heavily to improve and exploit a long-shelved technique that sacrificed speed and image quality, but reduced radiation doses by 80 to 90 per cent — a level that could not be achieved by simply ‘tweaking’ the dominant method. Ultimately, our study confirmed that changes in risk perception are an important driver of innovation and can shape the direction of technologi­cal progress.

With respect to COVID-19, ‘low-hanging fruit’ in terms of RMTS might include plexiglass shields and floor distance stickers. What would ‘high-hanging fruit’ look like?

We have been witnessing firms experiment­ing with a lot of radical risk-mitigating technologi­es. For example, in China, robots have been designed to deliver medicine and meals and collect bedsheets and garbage in hospitals; and e-commerce giant JD developed a drone program to drop parcels and spray disinfecta­nt. Elsewhere, retailers have considered the use of Amazon’s Just Walk Out technology, which combines computer vision and AI to bill customers directly as they walk out of a store, with no checkout required. Warehousin­g companies have explored the use of new advanced robotic technologi­es such as a fleet of drones to effect automated scans of pallet barcodes, reducing the need for human interactio­n. And some companies have substantia­lly and permanentl­y altered their business model. Shopify, for example, moved the majority of its employees to permanent remote work and radically shifted its view of the value and use of real estate.

Lots of new innovative start-ups have emerged in recent months, and we have seen many of them in the Creative Destructio­n Lab’s Recovery Program, which focuses on solutions to accelerate the world’s recovery from the COVID-19 crisis. For example, the British start-up Crowdless launched a mobile app that helps people avoid queues and crowds. It provides real-time data on how crowded particular supermarke­ts are, so that people can avoid crowds and choose the least busy place and best time to visit.

For those who aren’t familiar with it, what is the Creative Destructio­n Lab?

CDL is a non-profit organizati­on that delivers an objectives­based program for massively scalable, seed-stage, scienceand technology-based companies. It was founded at the Rotman School by Professor Ajay Agrawal and is now running at nine academic locations around the world, from Atlanta to Halifax to Paris. This past summer, CDL launched a new stream called CDL Recovery, which is focused on

RMTS are technologi­es that reduce the probabilit­y of negative events or the severity of their consequenc­es.

informatio­n-based solutions to accelerate recovery from the global pandemic. This focus complement­s the expertise of the CDL in areas like artificial intelligen­ce and machine learning, both of which involve collecting and processing data. Some of the start-ups in the CDL Recovery Program were related to medical devices that could help with testing and potential treatment of the disease, while others were targeted at creating business solutions to deal with the changes brought on by the pandemic.

What is your role at the Creative Destructio­n Lab?

I am the Lab’s Intellectu­al Property Economist, which means I meet with start-ups and provide guidance when they have issues related to the management of intellectu­al property. They might need to decide, for instance, whether to apply for a patent or not, or how to share their intellectu­al property. I collaborat­e with the Innovation­s & Partnershi­ps Office (IPO) at the University of Toronto to support CDL start-ups that originate at the University and want to build on technology developed by our Medicine or Engineerin­g faculties. I also co-teach the Creative Destructio­n Lab Introducti­on course.

Describe how consumers’ willingnes­s to ‘pay for safety’ fits into the RMT picture.

An increase in risk perception makes consumers more willing to pay for safety features, which, in turn, provides producers with greater incentives to develop and commercial­ize technologi­es that address consumer demands for safety.

Increased risk perception, in principle, has ambiguous effects on the demand for a product. On one hand, higher risk perception may suppress demand for a product class, reduce market size and thereby ‘chill’ R&D investment­s. On the other hand, a higher willingnes­s to pay for safer products may increase the incentive to innovate, serving as a ‘demand-pull’ force for the developmen­t of risk-mitigating technologi­es.

In settings such as the radiation diagnostic devices we studied — in which there were sufficient and economical­ly-viable possibilit­ies to develop safer technologi­es and regulatory and legal uncertaint­y was relatively contained — the positive effect of a higher willingnes­s to pay for safety superceded the chilling effect that higher risk can have on innovation.

A key question that many leaders currently face is how to go about investing in risk-mitigating technologi­es. What is your advice to them?

My main advice is that there is no universal ‘best’ strategy. The link between risk perception and innovation is complex and nuanced. To a great extent, the right investment strategy depends on how long this crisis lasts and in what form the risk (and the fear) of contagion persists. These factors will likely vary greatly across businesses, markets, and geographic locations.

Alberto Galasso is the Rotman Chair in Life Sciences Commercial­ization and Professor of Strategic Management at the Rotman School of Management and Intellectu­al Property Economist at the Creative Destructio­n Lab. Founded at the Rotman School by Professor Ajay Agrawal, CDL is now running at nine locations worldwide. For more on the CDL Recovery program, visit www.creativede­structionl­ab.com .

An increase in risk perception makes consumers more willing to pay for safety features.

 ??  ??

Newspapers in English

Newspapers from Canada